Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.46 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9303097 | 0.84 | PNMT (0.44) | PSIP1ALDH1A1CYP3A4CYP2C9HPGD | |
| SCHEMBL775887 | 0.83 | PSIP1 (0.50) | PSIP1HSD11B1HTR6ALDH1A1APOBEC3G | |
| SCHEMBL19248406 | 0.83 | PSIP1 (0.56) | PSIP1HSD11B1HTR6ALDH1A1CYP3A4 | |
| SCHEMBL776676 | 0.80 | ALDH1A1 (0.43) | HSD11B1ALDH1A1CA1CA2KMT2A | |
| SCHEMBL19239760 | 0.79 | PSIP1 (0.52) | PSIP1HSD11B1HTR6ALDH1A1CYP3A4 | |
| SCHEMBL7967868 | 0.79 | PSIP1 (0.56) | PSIP1HSD11B1HTR6ALDH1A1POLB | |
| SCHEMBL776537 | 0.78 | PSIP1 (0.50) | PSIP1HSD11B1HTR6ALDH1A1CA2 | |
| SCHEMBL23501536 | 0.78 | GAA (0.55) | HTR6ALDH1A1CYP3A4CYP2C9TDP1 | |
| SCHEMBL3109115 | 0.78 | PLCG1 (0.59) | HSD11B1ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL8795743 | 0.78 | CA2 (0.52) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120473558-A | Solid electrolyte, solid battery, preparation method of solid electrolyte and power utilization device | 深圳供电局有限公司 | 2025-08-12 | — | — | CN | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-11466375-B1 | Low temperature lithium production | Consolidated Nuclear Security, LLC (US) | 2022-10-11 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-10718057-B1 | Low temperature lithium production | Consolidated Nuclear Security, LLC (US) | 2020-07-21 | — | — | US | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| CN-110198941-A | Pyrrolopyridine N- oxidized derivatives and its preparation method and application | 江苏豪森药业集团有限公司 | 2019-09-03 | — | — | CN | disclosed |
| US-20190229372-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| US-10333172-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-06-25 | — | — | US | disclosed |
| US-20150056503-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| EP-1451199-A4 | MAGNESIUM MEDIATED PREPARATION OF FLUORINATED ALKYLSILANES | UNIV SOUTHERN CALIFORNIA (US) | 2006-04-26 | — | — | EP | disclosed |
| US-6803477-B2 | EFFICIENT PREPARATION OF TRIFLUOROMETHYL- AND DIFLUORO-METHYLSILANES USING MAGNESIUM MEDIATED REDUCTION OF CHLOROSILANES REACTING WITH TRI- AND DIFLUOROMETHYL SULFIDES, SULFOXIDES AND SULFONES; AUTOCATALYSIS | UNIVERSITY OF SOUTHERN CALIFORNIA | 2004-10-12 | — | — | US | disclosed |
| EP-1451199-A2 | MAGNESIUM MEDIATED PREPARATION OF FLUORINATED ALKYLSILANES | University Of Southern California (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20030153778-A1 | Magnesium mediated preparation of fluorinated alkyl silanes | UNIVERSITY OF SOUTHERN CALIFORNIA | 2003-08-14 | — | — | US | disclosed |
| WO-2003048033-A2 | MAGNESIUM MEDIATED PREPARATION OF FLUORINATED ALKYLSILANES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2003-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030153778-A1 | Magnesium mediated preparation of fluorinated alkyl silanes | TST, STS, PFAS | PSIP1 292/4885HSD11B1 1371/4885HTR6 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.